首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1673585

多重檢測市場規模、佔有率及成長分析（按產品類型、技術、應用、最終用戶和地區）－2025 年至 2032 年產業預測

Multiplex Assay Market Size, Share, and Growth Analysis, By Product Type (Consumables, Instruments), By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays), By Technology, By Application, By End-User, By Region - Industry Forecast 2025-2032

出版日期: 2025年03月03日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計多重檢測市場規模在 2023 年將達到 37 億美元，並將從 2024 年的 40.5 億美元成長到 2032 年的 83.7 億美元，預測期內（2025-2032 年）的複合年成長率為 9.5%。

由於慢性病和感染疾病的日益普及以及多重檢測相對於傳統方法的優勢，全球多重檢測市場正在經歷顯著成長。伴同性診斷的使用日益廣泛，例如羅氏公司用於識別 dMMR固體癌的治療藥物已獲得 FDA核准，表明該領域前景光明。早期診斷可使非小細胞肺癌等癌症的存活率提高三倍，進一步凸顯了市場的擴張潛力。此外，生物標記檢驗和自動化系統的需求正在推動高通量檢測的需求。多重檢測廣泛應用於癌症、自體免疫疾病和神經退化性疾病等，對於早期發現和提高認知至關重要，最終推動市場成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司詳細資訊
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Lonza Group（Switzerland）
DiaSorin（Italy）
WuXi Biologics（China）
Seegene（South Korea）
Ayoxxa Biosystems（Germany）
Thermo Fisher Scientific（United States）
Bio-Rad Laboratories（United States）
Luminex Corporation（United States）
QIAGEN（Germany）
Illumina（United States）
Agilent Technologies（United States）
PerkinElmer（United States）
Merck KGaA（Germany）
Becton, Dickinson and Company（United States）
Roche Diagnostics（Switzerland）
Siemens Healthineers（Germany）
Danaher Corporation（United States）
Abbott Laboratories（United States）
Meso Scale Diagnostics（United States）
Quanterix Corporation（United States）

結論和建議

簡介目錄

Product Code: SQMIG35H2180

Multiplex Assay Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 4.05 billion in 2024 to USD 8.37 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The global multiplex assay market is experiencing significant growth driven by the increasing prevalence of chronic and infectious diseases and the advantages of multiplex assays over traditional methods. The rising utilization in companion diagnostics is particularly noteworthy, as evidenced by FDA approvals like Roche's for identifying dMMR solid tumors, indicating a promising future for this sector. Early disease diagnosis, which can triple survival rates for cancers such as non-small cell lung cancer, further emphasizes the market's expansion potential. Additionally, the validation of biomarkers and demand for automated systems bolster the need for high-throughput assays. With applications spanning cancer, autoimmune diseases, and neurodegenerative disorders, multiplex assays are pivotal in enhancing early detection and raising awareness, ultimately fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Multiplex Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Multiplex Assay Market Segments Analysis

Global Multiplex Assay Market is segmented by Product Type, Type, Technology, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software. Based on Type, the market is segmented into Protein Multiplex Assays, Nucleic Acid Multiplex Assays and Cell-based Multiplex Assays. Based on Technology, the market is segmented into Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-time PCR and Others. Based on Application, the market is segmented into Research & Development and Clinical Diagnostics. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Multiplex Assay Market

The increasing emphasis on personalized medicine is significantly fueling the growth of the multiplex assay market. These assays facilitate the simultaneous analysis of several biomarkers, which enhances patient stratification and leads to more tailored treatment options. By enabling healthcare providers to assess multiple health indicators at once, multiplex assays contribute to more accurate diagnoses and effective therapeutic strategies. This capability not only optimizes patient care but also supports the shift towards individualized therapies that cater to specific patient needs, thus reinforcing the demand for these advanced diagnostic tools in clinical settings.

Restraints in the Multiplex Assay Market

The multiplex assay market faces significant restraints primarily due to regulatory challenges that can hinder their widespread adoption. The complex nature of these assays necessitates obtaining regulatory approval, a process that is often time-consuming and financially burdensome. Such stringent requirements can deter manufacturers from developing and introducing new multiplex assays into the market, ultimately slowing innovation and limiting the availability of these advanced diagnostic tools. Consequently, the lengthy regulatory procedures may restrict market growth and access to potentially valuable multiplex assays that could significantly enhance diagnostic accuracy and efficiency across various medical applications.

Market Trends of the Multiplex Assay Market

The multiplex assay market is witnessing a significant trend towards the adoption of multiplex immunoassays, driven by their efficiency in measuring multiple protein targets within a single sample. This capability not only streamlines workflows but also enhances the accuracy and throughput of diagnostic testing, drug discovery, and biomarker identification processes. As healthcare continues to shift towards personalized medicine and more precise diagnostics, the demand for these assays is expected to grow steadily. Furthermore, advancements in technology that facilitate higher sensitivity and multiplexing capabilities are propelling market growth, positioning multiplex immunoassays as essential tools in clinical research and therapeutics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Multiplex Assay Market Size by Product Type & CAGR (2025-2032)

Market Overview
Consumables
Instruments
Software

Global Multiplex Assay Market Size by Type & CAGR (2025-2032)

Market Overview
Protein Multiplex Assays
- Planar Protein Assays
- Bead-based Protein Assays
- Others
Nucleic Acid Multiplex Assays
- Planar Nucleic Acid Assays
- Bead-based Nucleic Acid Assays
- Others
Cell-based Multiplex Assays

Global Multiplex Assay Market Size by Technology & CAGR (2025-2032)

Market Overview
Flow Cytometry
Fluorescence Detection
Luminescence
Multiplex Real-time PCR
Others

Global Multiplex Assay Market Size by Application & CAGR (2025-2032)

Market Overview
Research & Development
- Drug Discovery & Development
- Biomarker Discovery & Validation
Clinical Diagnostics
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Autoimmune Diseases
- Nervous System Disorders
- Metabolism & Endocrinology Disorders
- Other Diseases

Global Multiplex Assay Market Size by End-User & CAGR (2025-2032)

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Others

Global Multiplex Assay Market Size & CAGR (2025-2032)

North America (Product Type, Type, Technology, Application, End-User)
- US
- Canada
Europe (Product Type, Type, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi Biologics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ayoxxa Biosystems (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meso Scale Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quanterix Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments